The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Eloxx Pharmaceuticals, Inc(NASDAQ:ELOX)


Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribonucleic acid modulating drug candidates for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical t...
Website: http://www.eloxxpharma.com
Founded: 1999
Full Time Employees: 29
Sector: Healthcare
Industry: Biotechnology
Eloxx Pharmaceuticals Op Cashflow Per Share ttm
Eloxx Pharmaceuticals Free Cashflow Per Share ttm
Eloxx Pharmaceuticals Cash Per Share ttm
Eloxx Pharmaceuticals (GAAP) P/E ratio ttm
Eloxx Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.